Net Profit Margins
Novavax, Inc.’s revenue jumped 443.08% since last year same period to $424.43Mn in the Q2 2023. On a quarterly growth basis, Novavax, Inc. has generated 6702.77% jump in its revenue since last 3-months.
Novavax, Inc.’s net profit jumped 111.36% since last year same period to $58.01Mn in the Q2 2023. On a quarterly growth basis, Novavax, Inc. has generated 119.74% jump in its net profits since last 3-months.
Novavax, Inc.’s net profit margin jumped 102.09% since last year same period to 13.67% in the Q2 2023. On a quarterly growth basis, Novavax, Inc. has generated -99.7% fall in its net profit margins since last 3-months.
EPS Estimate Current Quarter
EPS Estimate Current Year
Novavax, Inc.’s earning per share (EPS) estimates for the current quarter stand at -1.14 - a -172.61% fall from last quarter’s estimates.
Novavax, Inc.’s earning per share (EPS) estimates for the current year stand at -1.14.
Return on Assets (ROA)
Return on Equity (ROE)
Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Novavax, Inc.’s return on assets (ROA) stands at -0.18.
The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Novavax, Inc.’s return on equity (ROE) stands at -8.98.
|Earnings Date||Estimated EPS||Reported EPS||Surprise %|